TORONTO, Nov. 21, 2017 /PRNewswire/ – Baylis Medical Company Inc. has launched a hands-on workshop in Europe that will train cardiologists on innovative tools that enable access to the heart from any approach. This includes a growing number of procedures that require physicians to use major veins that feed into the heart from above […]
Coronary/Structural Heart
HeartStitch® “Sutures The Future” at the TCT in Denver, Colorado
FOUNTAIN VALLEY, Calif., Nov. 20, 2017 /PRNewswire/ — TCT 2017 in Denver, Colorado, provided a forum for Interventional Cardiologists from around the world to discover the HeartStitch® Suture-Based Solutions to Structural Heart Procedures. These key procedures of interest include septal repair, mitral and tricuspid valve repair and new access and closure techniques, all areas HeartStitch® has […]
Xeltis Closes $52M for Replacement Heart Valve Programs
EINDHOVEN, The Netherlands and ZURICH, November 15, 2017 /PRNewswire/ — Xeltis, a clinical-stage medical device company pioneering a restorative approach in heart valve therapy, today announced the completion of an oversubscribed EUR45 million ($52 million) Series C financing. The funding round was led by a global strategic investor with participation […]
Corvia Medical Announces Enrollment of First Patients in Pivotal Trial of the IASD System II for the Treatment of Heart Failure
ANAHEIM, Calif., Nov. 14, 2017 /PRNewswire/ — Corvia Medical, Inc., a privately-held medical device company that developed a first-in-class transcatheter structural heart device to treat heart failure, today announced that it has enrolled the first patients in its global multicenter trial (REDUCE LAP-HF II) of the Interatrial Shunt Device (IASD) […]
Plaxgen Plaque Array Lipid-Modifying Drugs Study Published in Journal of Visualized Experiments
FREMONT, Calif., Nov. 13, 2017 /PRNewswire/ — Plaxgen Inc,developing flow cytometry-based blood diagnostics for plaque-associated diseases, such as atherosclerosis and Alzheimer’s, announced that new research exploring the effect of lipid-lowering drugs, including statins, on the morphology of cholesterol particles in human serum samples was published in the peer-reviewed journal, “Journal of […]
Cambridge’s PlaqueTec Names Former Dimension Therapeutics CEO as New Leader
CAMBRIDGE, England, November 13, 2017 /PRNewswire/ — The Board of Directors of PLAQUETEC LTD (‘PlaqueTec’) today announced the appointment of Annalisa Jenkins, MBBS, FRCP, as the company’s Chief Executive Officer. Dr. Jenkins, most recently CEO of U.S.-based Dimension Therapeutics, will lead the 2018 launch of the pioneering biomarker-based PlaqueTec Liquid Biopsy System(TM) […]
SentreHEART Announces Participation at American Heart Association Scientific Sessions 2017
REDWOOD CITY, Calif.–(BUSINESS WIRE)– SentreHEART, Inc., the manufacturer of the LARIAT® Suture Delivery Device (LARIAT) will be participating in the American Heart Association (AHA) Scientific Sessions 2017 in Anaheim, California November 11-15, 2017. AHA’s Scientific Sessions attracts nearly 18,000 attendees, with a global presence from more than 100 countries. With a commitment to […]
The Biggest Breakthrough Since Statins
A new study shows that anti-inflammatory injections may lower the risk of heart attacks. Researchers are saying this is the biggest cardiology breakthrough since statins. In the study, heart attack survivors that were given injections of the anti-inflammatory drug canakinumab had fewer attacks in the future. Incidentally, death from cancer decreased by […]
Clinical Trial Targets Devastating Heart Failure Diagnosis
CHICAGO, Nov. 6, 2017 /PRNewswire-USNewswire/ — Lynne Austin found she was increasingly out of breath doing even the simplest of tasks as 2015 came to a close. She couldn’t walk more than a few steps at a time. She couldn’t breathe. Her health was rapidly deteriorating and she wasn’t sure she would get […]
CryoLife Announces Enrollment of First Patients in BioGlue Clinical Trial in China
ATLANTA, Nov. 6, 2017 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY),a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today that enrollment has started in the Company’s BioGlue clinical trial in China. The results from the trial will serve as the basis of the Company’s regulatory submission […]



